Hospital opioid treatment study tests best way to help patients

NCT ID NCT04921787

Ongoing Disease control Sponsor: Gavin Bart Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at two different approaches to help community hospitals start treating opioid use disorder in patients. One approach is basic training and education, while the other adds extra support like practice facilitation. The goal is to see which method works better at getting patients to continue treatment after they leave the hospital.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Training and education vs. practice facilitation
What this could lead to: If successful, this could show how to effectively implement opioid treatment programs in community hospitals, increasing access to care.
What could go wrong: This is a small, early-stage implementation study with only 24 hospitals, so results may not apply broadly. It tests strategies, not a direct treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER, MODERATE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

follicular lymphoma opiate dependence substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OPIOID USE DISORDER, MODERATE OPIOID USE DISORDER, SEVERE SUBSTANCE USE DISORDERS

Contacts and locations

Locations

Boston University

Boston, Massachusetts, 02119, United States
Hennepin Healthcare Research Institute

Minneapolis, Minnesota, 55404, United States
New York University

New York, New York, 10016, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.